This “interferon signature,” pervasive across SLE, SSc, and myositis, lowers B-cell activation thresholds, promotes class-switch recombination, and drives BAFF (B-cell activating factor) expression. The gene discussed is TNFSF13B; the disease is systemic sclerosis.